SCHEDULE: FMR LLC Reduces Stake in Fortrea Holdings to 3.4%

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a beneficial ownership of 3.4% in Fortrea Holdings Inc. as of June 30, 2025.

Summary

• FMR LLC and Abigail P. Johnson jointly reported beneficial ownership of 3,071,083.38 shares of Fortrea Holdings Inc. Common Stock.
• This represents 3.4% of the class of securities outstanding.
• FMR LLC holds sole voting power over 3,045,201.00 shares and sole dispositive power over 3,071,083.38 shares.
• Abigail P. Johnson, as a control person of FMR LLC, is deemed to beneficially own the same aggregate amount of shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership, which is neutral in tone. While a reduction in stake by a major investor (implied by Amendment No. 4 and the 3.4% figure, which is below the 5% threshold for initial 13G filings) could be interpreted negatively by the market, the document itself does not express sentiment or operational performance.

Future Outlook

NA

Industry Context

This filing is a routine disclosure by a significant institutional investor, FMR LLC (Fidelity Management & Research Company LLC), regarding its passive ownership stake in Fortrea Holdings Inc. Such filings provide transparency on major shareholder positions, which can be of interest to other investors tracking institutional sentiment and portfolio allocations within the pharmaceutical services or contract research organization (CRO) industry.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional investor's reduced stake, which may influence investment decisions.

Key Dates

Keywords

Fortrea Holdings Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Stake Disclosure